Home of the sheep, land of the slave.
btw, oh yeah and the new Biometrics Agency is just for the military...It won't possibly be used against the American citizens some day.
Oh yeah, and James Lovelock wants "a few people with authority" to run the planet. This is the man Al Gore listens to, and John Holdren, and James Hansen from NASA.
Reconciliation Act H.R.4872 Brings Microchipping to America
SkyWatch Canada
Infowars.com
March 30, 2010
But as usual the wording of this bill permits the creation of something entirely quite different. In 2004 the FDA approved the Verichip for use of storing medical records. This device was classified as a Class II medical device. This is most likely the Class II implantable device being referred to in this section of the bill. The bill allows the unique device identifier (Chip ID tag) to be linked to “postmarket safety patient outcome data” regarding the implantable device itself. In order “to facilitate the analyses of postmarket safety and patient outcomes” the health secretary will examine ways to gain access to Medicare health records, private sector health records and other data deemed necessary (including surveillance data) by the Health Secretary and then link it to the database and your RFID implant. Just to be accurate, section (3) defines “data” as “claims data, patient survey data, standardized analytic files that allow for the pooling and analysis of data from disparate data environments, electronic health records, and any other data deemed appropriate by the secretary.”
So basically this bill creates a National Database of any type of data deemed appropriate by the executive branch of the US Federal Government. This could literally be anything. This could include anything you might have expected to find in an East German Stasi file. All of this data will then be linked to a “Class II implantable device” under your skin. There you have it, just like Lindsey Williams warned us. Forget the national ID card, implantable microchips are coming to a clinic near you no later than 36 months after the bill is signed into law.
1 (1) IN GENERAL.—Section 519 of the Federal
2 Food, Drug, and Cosmetic Act (21 U.S.C. 360i) is
3 amended—
4 (A) by redesignating subsection (g) as sub
5 section (h); and
6 (B) by inserting after subsection (f) the
7 following:
8 ‘‘National Medical Device Registry
9 ‘‘(g)(1) The Secretary shall establish a national med
10 ical device registry (in this subsection referred to as the
11 ‘registry’) to facilitate analysis of postmarket safety and
12 outcomes data on each device that—
13 ‘‘(A) is or has been used in or on a patient; and
14 ‘‘(B) is—
15 ‘‘(i) a class III device; or
16 ‘‘(ii) a class II device that is implantable,
17 life-supporting, or life-sustaining.
18 ‘‘(2) In developing the registry, the Secretary shall,
19 in consultation with the Commissioner of Food and Drugs,
20 the Administrator of the Centers for Medicare & Medicaid
21 Services, the head of the Office of the National Coordi
22 nator for Health Information Technology, and the Sec
23 retary of Veterans Affairs, determine the best methods
24 for—
1 ‘‘(A) including in the registry, in a manner con
2 sistent with subsection (f), appropriate information
3 to identify each device described in paragraph (1) by
4 type, model, and serial number or other unique iden
5 tifier;
6 ‘‘(B) validating methods for analyzing patient
7 safety and outcomes data from multiple sources and
8 for linking such data with the information included
9 in the registry as described in subparagraph (A), in
10 cluding, to the extent feasible, use of—
11 ‘‘(i) data provided to the Secretary under
12 other provisions of this chapter; and
13 ‘‘(ii) information from public and private
14 sources identified under paragraph (3);
15 ‘‘(C) integrating the activities described in this
16 subsection with—
17 ‘‘(i) activities under paragraph (3) of sec
18 tion 505(k) (relating to active postmarket risk
19 identification);
20 ‘‘(ii) activities under paragraph (4) of sec
21 tion 505(k) (relating to advanced analysis of
22 drug safety data); and
23 ‘‘(iii) other postmarket device surveillance
24 activities of the Secretary authorized by this
25 chapter; and
1 ‘‘(D) providing public access to the data and
2 analysis collected or developed through the registry
3 in a manner and form that protects patient privacy
4 and proprietary information and is comprehensive,
5 useful, and not misleading to patients, physicians,
6 and scientists.
7 ‘‘(3)(A) To facilitate analyses of postmarket safety
8 and patient outcomes for devices described in paragraph
9 (1), the Secretary shall, in collaboration with public, aca
10 demic, and private entities, develop methods to—
11 ‘‘(i) obtain access to disparate sources of
12 patient safety and outcomes data, including—
13 ‘‘(I) Federal health-related electronic
14 data (such as data from the Medicare pro
15 gram under title XVIII of the Social Secu
16 rity Act or from the health systems of the
17 Department of Veterans Affairs);
18 ‘‘(II) private sector health-related
19 electronic data (such as pharmaceutical
20 purchase data and health insurance claims
21 data); and
22 ‘‘(III) other data as the Secretary
23 deems necessary to permit postmarket as
24 sessment of device safety and effectiveness;
25 and
1 ‘‘(ii) link data obtained under clause (i)
2 with information in the registry.
3 ‘‘(B) In this paragraph, the term ‘data’ refers to in
4 formation respecting a device described in paragraph (1),
5 including claims data, patient survey data, standardized
6 analytic files that allow for the pooling and analysis of
7 data from disparate data environments, electronic health
8 records, and any other data deemed appropriate by the
9 Secretary.
10 ‘‘(4) Not later than 36 months after the date of the
11 enactment of this subsection, the Secretary shall promul
12 gate regulations for establishment and operation of the
13 registry under paragraph (1). Such regulations—
14 ‘‘(A)(i) in the case of devices that are described
15 in paragraph (1) and sold on or after the date of the
16 enactment of this subsection, shall require manufac
17 turers of such devices to submit information to the
18 registry, including, for each such device, the type,
19 model, and serial number or, if required under sub
20 section (f), other unique device identifier; and
21 ‘‘(ii) in the case of devices that are described in
22 paragraph (1) and sold before such date, may re
23 quire manufacturers of such devices to submit such
24 information to the registry, if deemed necessary by
25 the Secretary to protect the public health;
1 ‘‘(B) shall establish procedures—
2 ‘‘(i) to permit linkage of information sub
3 mitted pursuant to subparagraph (A) with pa
4 tient safety and outcomes data obtained under
5 paragraph (3); and
6 ‘‘(ii) to permit analyses of linked data;
7 ‘‘(C) may require device manufacturers to sub
8 mit such other information as is necessary to facili
9 tate postmarket assessments of device safety and ef
10 fectiveness and notification of device risks;
11 ‘‘(D) shall establish requirements for regular
12 and timely reports to the Secretary, which shall be
13 included in the registry, concerning adverse event
14 trends, adverse event patterns, incidence and preva
15 lence of adverse events, and other information the
16 Secretary determines appropriate, which may include
17 data on comparative safety and outcomes trends;
18 and
19 ‘‘(E) shall establish procedures to permit public
20 access to the information in the registry in a manner
21 and form that protects patient privacy and propri
22 etary information and is comprehensive, useful, and
23 not misleading to patients, physicians, and sci
24 entists.
1 ‘‘(5) To carry out this subsection, there are author
2 ized to be appropriated such sums as may be necessary
3 for fiscal years 2010 and 2011.’’.
4 (2) EFFECTIVE DATE.—The Secretary of
5 Health and Human Services shall establish and
6 begin implementation of the registry under section
7 519(g) of the Federal Food, Drug, and Cosmetic
8 Act, as added by paragraph (1), by not later than
9 the date that is 36 months after the date of the en
10 actment of this Act, without regard to whether or
11 not final regulations to establish and operate the
12 registry have been promulgated by such date.
13 (3) CONFORMING AMENDMENT.—Section
14 303(f)(1)(B)(ii) of the Federal Food, Drug, and
15 Cosmetic Act (21 U.S.C. 333(f)(1)(B)(ii)) is amend
16 ed by striking ‘‘519(g)’’ and inserting ‘‘519(h)’’.
17 (b) ELECTRONIC EXCHANGE AND USE IN CERTIFIED
18 ELECTRONIC HEALTH RECORDS OF UNIQUE DEVICE
19 IDENTIFIERS.—
THEY WANT TO CONTROL YOU
THEY WANT TO KNOW WHAT YOU DO
THEY WANT TO KNOW WHERE YOU GO
THEY WANT TO KNOW HOW MUCH YOU SPEND...
...AND ON WHAT
THEY WANT TO KNOW WHO YOU TALK TO
THEY WANT TO KNOW WHAT YOUR THOUGHTS ARE...
...BEFORE YOU HAVE THEM
THEY WANT YOU TO LINK YOUR FRIENDS TOGETHER SO...
THEY CAN TRACK YOUR RELATIONSHIPS...
...NO MATTER HOW DIVERSE
ALL IN THE NAME OF PROTECTION
I FEEL SAFER ALREADY
No comments:
Post a Comment